Myo-inositol and Selenium for Indeterminate Thyroid Nodules
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether taking myo-inositol and selenium supplements can help reduce the risk of thyroid cancer in people with thyroid nodules that are considered 'indeterminate' (TIR3a). The goal is to see if these supplements can prevent the nodules from becoming cancerous.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a thyroid nodule that was classified as TIR3a (indeterminate) after a fine needle aspiration biopsy.
- You have given written consent and have enough tissue sample for special testing.
- You do not have a diagnosis of thyroid cancer or other malignant thyroid conditions.
- Your thyroid function (TSH) is normal and you do not need to start thyroid hormone medication.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a decision-support tool to help people make choices about care for thyroid nodules that look indeterminate to cancer on biopsy. It may help you understand options and decide next steps more confidently.
This study looks at how doctors talk with patients who have a thyroid nodule that may need a biopsy. It aims to improve communication and help patients feel more involved in their care.
This study looks at your thyroid nodule to better understand if it might be cancer. They use your medical history, ultrasound, and special tests to help figure out the risk, which may help you make decisions about treatment.
This study is testing whether it is safe to simply monitor (watch closely) a small thyroid nodule that has a certain biopsy result (Bethesda IV) instead of removing it right away. You would not receive a treatment, but would have regular checkups and ultrasounds to see if the nodule changes.
This study compares a new 3D technology to standard ultrasound for measuring thyroid nodule volume. It may help doctors better track changes in nodules over time.
This trial uses a special imaging technique to look at the tiny blood vessels inside thyroid nodules before they are removed. It may help doctors understand which nodules are cancerous.
Hear when a new Thyroid Nodule trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.